By expenditures
| Name | Title | Type |
|---|---|---|
| Angela Westwoord | Chief Financial Officer | Auditee |
| Lori Budnick | Principal | Auditee |
| Mary Kay Curtiss | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 350577 | 2024 | 2025-03-31 | Cliftonlarsonallen LLP | $1.39M |
| 335760 | 2024 | 2025-01-03 | Cliftonlarsonallen LLC | $3.04M |
| 295318 | 2023 | 2024-03-15 | Cliftonlarsonallen LLP | $1.33M |
| 10021 | 2023 | 2024-01-08 | Cliftonlarsonallen LLP | $1.83M |
| 56859 | 2022 | 2023-03-23 | Cliftonlarsonallen LLP | $1.35M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 350577 | 2024 | 2025-03-31 | 1117413 | 2024-002 | Significant Deficiency | - | N |
| 350577 | 2024 | 2025-03-31 | 1117412 | 2024-001 | Significant Deficiency | Yes | A |
| 350577 | 2024 | 2025-03-31 | 1117411 | 2024-002 | Significant Deficiency | - | N |
| 350577 | 2024 | 2025-03-31 | 1117410 | 2024-001 | Significant Deficiency | Yes | A |
| 350577 | 2024 | 2025-03-31 | 540971 | 2024-002 | Significant Deficiency | - | N |
| 350577 | 2024 | 2025-03-31 | 540970 | 2024-001 | Significant Deficiency | Yes | A |
| 350577 | 2024 | 2025-03-31 | 540969 | 2024-002 | Significant Deficiency | - | N |
| 350577 | 2024 | 2025-03-31 | 540968 | 2024-001 | Significant Deficiency | Yes | A |
| 335760 | 2024 | 2025-01-03 | 1094161 | 2024-001 | Significant Deficiency | - | P |
| 335760 | 2024 | 2025-01-03 | 1094160 | 2024-001 | Significant Deficiency | - | P |
| 335760 | 2024 | 2025-01-03 | 517719 | 2024-001 | Significant Deficiency | - | P |
| 335760 | 2024 | 2025-01-03 | 517718 | 2024-001 | Significant Deficiency | - | P |
| 295318 | 2023 | 2024-03-15 | 956969 | 2023-001 | Significant Deficiency | Yes | B |
| 295318 | 2023 | 2024-03-15 | 956968 | 2023-001 | Significant Deficiency | Yes | B |
| 295318 | 2023 | 2024-03-15 | 380527 | 2023-001 | Significant Deficiency | Yes | B |
| 295318 | 2023 | 2024-03-15 | 380526 | 2023-001 | Significant Deficiency | Yes | B |
| 56859 | 2022 | 2023-03-23 | 638056 | 2022-005 | Significant Deficiency | - | B |
| 56859 | 2022 | 2023-03-23 | 638055 | 2022-004 | Significant Deficiency | - | B |
| 56859 | 2022 | 2023-03-23 | 638054 | 2022-003 | Material Weakness | - | E |
| 56859 | 2022 | 2023-03-23 | 638053 | 2022-002 | Material Weakness | Yes | E |
| 56859 | 2022 | 2023-03-23 | 638052 | 2022-005 | Significant Deficiency | - | B |
| 56859 | 2022 | 2023-03-23 | 638051 | 2022-004 | Significant Deficiency | - | N |
| 56859 | 2022 | 2023-03-23 | 638050 | 2022-003 | Material Weakness | - | E |
| 56859 | 2022 | 2023-03-23 | 638049 | 2022-002 | Material Weakness | Yes | E |
| 56859 | 2022 | 2023-03-23 | 61614 | 2022-005 | Significant Deficiency | - | B |
| 56859 | 2022 | 2023-03-23 | 61613 | 2022-004 | Significant Deficiency | - | B |
| 56859 | 2022 | 2023-03-23 | 61612 | 2022-003 | Material Weakness | - | E |
| 56859 | 2022 | 2023-03-23 | 61611 | 2022-002 | Material Weakness | Yes | E |
| 56859 | 2022 | 2023-03-23 | 61610 | 2022-005 | Significant Deficiency | - | B |
| 56859 | 2022 | 2023-03-23 | 61609 | 2022-004 | Significant Deficiency | - | N |
| 56859 | 2022 | 2023-03-23 | 61608 | 2022-003 | Material Weakness | - | E |
| 56859 | 2022 | 2023-03-23 | 61607 | 2022-002 | Material Weakness | Yes | E |